In Part 2 of his interview with HCA News, David Engelhardt, the founder of ReadyDock Inc., discussed the company's chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. Here, Engelhardt details how ReadyDock’s technology works and infection-causing bacteria it can kill.
David Engelhardt, the founder of ReadyDock Inc., met up with HCA News for an interview at the HIMSS17 conference in Orlando, Florida. ReadyDock is chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. In this section, Engelhardt speaks of the severity and complexity of the infection issue.
At HIMSS 2017, Patricia Sengstack led a conversation peppered with allusions to books and films from recent memory, bringing a certain levity to the weighty and important topic of patient safety. IT can help enormously, but also create problems of its own.
Trivalent’s Vice President of Products Yiannis Vassiliades sat down with HCA News to talk about challenges for the industry and the HIMSS experience.
Yiannis Vassiliades of Trivalent details how building data security for defense informs healthcare information security.
At HIMSS17 in Orlando, Florida, Yiannis Vassiliades of Trivalent spoke with HCA News about the cybersecurity risks associated with the healthcare industry, giving a basic example of the potential problems seen in day-to-day life and detailing his background in IT security and his organization’s aims.
At HIMSS17 in Orlando, Florida, HCA News spoke with Ashish Sharma, Chief Marketing Officer at Spectralink. Spectralink's communications technology is nearly ubiquitous in hospitals, and Sharma discussed the move from simple, utilitarian devices to the creation of new, integrated touchscreen units.
“I think we’re agreeing, but in a way that sounds like we disagree."
The main goal, he said, was not merely insuring compliance to regulation, but instead insuring actual security.
The app maker announced results from a study that reinforce the potential of telehealth as a tool to help patients manage blood sugar.
With its slice of the wearable fitness monitor market negligible, Jawbone has accused Fitbit, its former competitor in the consumer space, of stealing trade secrets. A hearing is scheduled for later today.
Goldberg sat down with Healthcare Analytics News to discuss the platform’s goal of delivering real-world data to oncology departments in order to expedite transitions to value-based models and provide attuned patient care.
Mr. DiCicco of GlaxoSmithKline speaks about an iPhone-based rheumatoid arthritis study combining patient-response surveys with the device's motion sensor capabilities.
It isn't just a fashion statement: it might also be a breakthrough.
The company is confident in the system, with CEO Jim Pearson saying he believes that “it will revolutionize the intracranial neurosurgical market."
Patents had protected Teva's monopoly on 40mg glatiramer acetate injections until a court ruling yesterday seemingly left the market open for generic competition.
With waning domestic sales hurting producers and analysts proposing a government takeover hypothetical, two new treatments have been approved in Europe.
An old standby steps back to the plate as a new entry is abandoned amidst disappointing trials, devastating its maker’s stock value.
Jim O’Neill and Balaji Srinivasan, both of whom have made controversial statements on regulation, met with President-Elect Trump last week.
For Dr. Harrold, studies of the expansive data set underscore a need for an emphasis on the individual characteristics that make each RA case unique.
The project, which could provide useful theory for public health response, hinges on the notion of “critical slowing down,” to determine the tipping point.
Speaking at AAO 2016, they stressed that the program is designed to supplement careful diagnosis and cut costs.
Clostridium difficile infections (C. difficile) are common, costly, and potentially fatal. But UV light can kill them.
It may be possible soon to create bones from transplant using a 3d printer, thanks to a new ink developed at Northwestern.
